IDO1 and depressive symptom measurement: Consistent with previous reports that depression is associated with increased IDO1 expression [30, 31], qPCR analysis showed that CUMS treatment significantly upregulated IDO1 [T=5.237, P=0.006] in the DRN (Figure 2A).